AstraZeneca Ready to Scrap Plans for US Approval of COVID Shot

An AstraZeneca executive said the British drugmaker would consider not submitting its COVID-19 vaccine for approval in the United States if the regulatory process takes too long.
Reuters Health Information

source https://www.medscape.com/viewarticle/970480?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost